pharmaphorum

J&J bets on Isomorphic for AI-powered drug hunt

Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...
FierceBiotech

Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model

AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...
Benzinga.com

Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery

Isomorphic Labs, a London-based spin-out of Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google's AI R&D division DeepMind, has announced strategic partnerships with Eli Lilly And Co (NYSE:LLY) and ...
SiliconANGLE

Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
Wall Street Journal

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

Isomorphic Labs raised $600 million in its first external funding round to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.
FierceBiotech

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM

Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. The two separate pacts ...
SiliconANGLE

AI drug discovery startup Isomorphic Labs partners with Eli Lilly and Novartis

London-based Isomorphic Labs Ltd., a drug discovery-focused artificial intelligence startup that was spun out of Google LLC’s DeepMind unit just over two years ago, today announced key partnerships ...